Differential Expression of E-cadherin, β-catenin, and Lewis X Between Invasive Hydatidiform Moles and Post-molar Choriocarcinomas
Overview
Molecular Biology
Pathology
Authors
Affiliations
Trophoblast cell adhesion and migration are carefully coordinated during normal placental development. We have compared the expression of three adhesion molecules, E-cadherin, β-catenin, and Lewis x, by immunohistochemistry during normal trophoblast differentiation, and in hydatidiform moles and choriocarcinomas. Both E-cadherin and β-catenin were expressed in normal placenta cytotrophoblast, and this expression decreased with trophoblast maturation. E-cadherin was mainly localized along the contact between cytotrophoblast and syncytiotrophoblast, which indicates its role in the differentiation of the syncytial layer. Lewis x disappeared progressively during differentiation of normal villous vessels, and was expressed in molar pregnancies. Interestingly, whereas choriocarcinomas were not, or poorly, stained, invasive hydatidiform moles (invHMs) strongly expressed Lewis x in vascular structures. This observation correlated well with E-cadherin and β-catenin expression and suggests that these three markers are associated with the invasive transformation. The presence of robust endothelial structures in invHMs could also explain their ability to maintain organized villous architecture (contrary to metastatic choriocarcinomas) during their invasion of extrauterine tissues such as the lung or the brain after dissemination through the blood flow. In our hands, Lewis x appeared to be a new, reliable marker that can be used to clearly distinguish invHMs from choriocarcinomas.
Epigenetic Dysregulation of Trophoblastic Gene Expression in Gestational Trophoblastic Disease.
Szabolcsi Z, Demeter A, Kiraly P, Balogh A, Wilson M, King J Biomedicines. 2021; 9(12).
PMID: 34944751 PMC: 8698431. DOI: 10.3390/biomedicines9121935.
Ma Z, Yang H, Peng L, Kuhn C, Chelariu-Raicu A, Mahner S Front Immunol. 2021; 12:679424.
PMID: 34135905 PMC: 8202085. DOI: 10.3389/fimmu.2021.679424.
Understanding and management of gestational trophoblastic disease.
Ning F, Hou H, Morse A, Lash G F1000Res. 2019; 8.
PMID: 31001418 PMC: 6464061. DOI: 10.12688/f1000research.14953.1.
Dubruc E, Allias F, Morel A, Golfier F, Puisieux A, Devouassoux-Shisheboran M Virchows Arch. 2019; 475(1):121-125.
PMID: 30847562 DOI: 10.1007/s00428-019-02551-7.
Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma.
Huebner H, Strick R, Wachter D, Kehl S, Strissel P, Schneider-Stock R J Exp Clin Cancer Res. 2017; 36(1):165.
PMID: 29169400 PMC: 5701501. DOI: 10.1186/s13046-017-0634-x.